4.5 Review

To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition

Journal

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbamcr.2009.08.006

Keywords

Zinc-binding group; Mechanism-based inhibitor; MMP

Funding

  1. University of California, San Diego
  2. National Institutes of Health [R01 HL00049-01, 5 T32 HL007444-27]
  3. American Heart Association [0970028N]
  4. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007444] Funding Source: NIH RePORTER

Ask authors/readers for more resources

This short review highlights some recent advances in matrix metalloproteinase inhibitor (MMPi) design and development. Three distinct approaches to improved MMP inhibition are discussed: (1) the identification and investigation of novel zinc-binding groups (ZBGs), (2) the study of non-zinc-binding MMPi, and (3) mechanism-based MMPi that form covalent adducts with the protein. Each of these strategies is discussed and their respective advantages and remaining challenges are highlighted. The studies discussed here bode well for the development of ever more selective, potent, and well-tolerated MMPi for treating several important disease pathologies. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available